nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR2C—metabolic syndrome X	0.673	1	CbGaD
Doxepin—Viral diarrhoea—Metformin—metabolic syndrome X	0.00968	0.0962	CcSEcCtD
Doxepin—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00702	0.127	CbGeAlD
Doxepin—HTR2A—arteriole—metabolic syndrome X	0.00662	0.12	CbGeAlD
Doxepin—Sinus congestion—Metformin—metabolic syndrome X	0.00508	0.0505	CcSEcCtD
Doxepin—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00472	0.0856	CbGeAlD
Doxepin—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00422	0.0766	CbGeAlD
Doxepin—Fungal infection—Metformin—metabolic syndrome X	0.00327	0.0325	CcSEcCtD
Doxepin—Rhinorrhoea—Metformin—metabolic syndrome X	0.00312	0.031	CcSEcCtD
Doxepin—HTR2A—autonomic nervous system—metabolic syndrome X	0.00284	0.0515	CbGeAlD
Doxepin—Ear pain—Metformin—metabolic syndrome X	0.00215	0.0214	CcSEcCtD
Doxepin—Nasal congestion—Metformin—metabolic syndrome X	0.00201	0.02	CcSEcCtD
Doxepin—Lethargy—Metformin—metabolic syndrome X	0.00187	0.0186	CcSEcCtD
Doxepin—Pain in extremity—Metformin—metabolic syndrome X	0.00183	0.0182	CcSEcCtD
Doxepin—Migraine—Metformin—metabolic syndrome X	0.00181	0.0179	CcSEcCtD
Doxepin—HRH2—cardiovascular system—metabolic syndrome X	0.00176	0.032	CbGeAlD
Doxepin—Breast disorder—Metformin—metabolic syndrome X	0.00166	0.0165	CcSEcCtD
Doxepin—Cramp muscle—Metformin—metabolic syndrome X	0.00165	0.0164	CcSEcCtD
Doxepin—Nasopharyngitis—Metformin—metabolic syndrome X	0.00164	0.0163	CcSEcCtD
Doxepin—HTR2A—artery—metabolic syndrome X	0.00161	0.0292	CbGeAlD
Doxepin—Influenza—Metformin—metabolic syndrome X	0.00159	0.0157	CcSEcCtD
Doxepin—ADRA1B—kidney—metabolic syndrome X	0.0015	0.0273	CbGeAlD
Doxepin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00147	0.0146	CcSEcCtD
Doxepin—Infestation NOS—Metformin—metabolic syndrome X	0.00141	0.014	CcSEcCtD
Doxepin—Infestation—Metformin—metabolic syndrome X	0.00141	0.014	CcSEcCtD
Doxepin—Drowsiness—Metformin—metabolic syndrome X	0.00141	0.014	CcSEcCtD
Doxepin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00139	0.0138	CcSEcCtD
Doxepin—HTR2A—endothelium—metabolic syndrome X	0.00136	0.0247	CbGeAlD
Doxepin—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00134	0.0133	CcSEcCtD
Doxepin—Bradycardia—Metformin—metabolic syndrome X	0.00129	0.0128	CcSEcCtD
Doxepin—Hepatitis—Metformin—metabolic syndrome X	0.00127	0.0126	CcSEcCtD
Doxepin—Hypoaesthesia—Metformin—metabolic syndrome X	0.00126	0.0125	CcSEcCtD
Doxepin—HTR2A—blood vessel—metabolic syndrome X	0.00125	0.0227	CbGeAlD
Doxepin—Oedema peripheral—Metformin—metabolic syndrome X	0.00125	0.0124	CcSEcCtD
Doxepin—Connective tissue disorder—Metformin—metabolic syndrome X	0.00125	0.0124	CcSEcCtD
Doxepin—Eye disorder—Metformin—metabolic syndrome X	0.00119	0.0118	CcSEcCtD
Doxepin—Cardiac disorder—Metformin—metabolic syndrome X	0.00118	0.0117	CcSEcCtD
Doxepin—Flushing—Metformin—metabolic syndrome X	0.00118	0.0117	CcSEcCtD
Doxepin—CHRM2—cardiovascular system—metabolic syndrome X	0.00116	0.021	CbGeAlD
Doxepin—Angiopathy—Metformin—metabolic syndrome X	0.00115	0.0114	CcSEcCtD
Doxepin—Immune system disorder—Metformin—metabolic syndrome X	0.00115	0.0114	CcSEcCtD
Doxepin—Mediastinal disorder—Metformin—metabolic syndrome X	0.00114	0.0114	CcSEcCtD
Doxepin—Chills—Metformin—metabolic syndrome X	0.00114	0.0113	CcSEcCtD
Doxepin—Erythema—Metformin—metabolic syndrome X	0.0011	0.011	CcSEcCtD
Doxepin—Malnutrition—Metformin—metabolic syndrome X	0.0011	0.011	CcSEcCtD
Doxepin—HRH2—liver—metabolic syndrome X	0.00109	0.0198	CbGeAlD
Doxepin—Flatulence—Metformin—metabolic syndrome X	0.00109	0.0108	CcSEcCtD
Doxepin—Dysgeusia—Metformin—metabolic syndrome X	0.00108	0.0107	CcSEcCtD
Doxepin—Muscle spasms—Metformin—metabolic syndrome X	0.00106	0.0106	CcSEcCtD
Doxepin—CHRM1—cardiovascular system—metabolic syndrome X	0.00105	0.0191	CbGeAlD
Doxepin—HTR2B—cardiovascular system—metabolic syndrome X	0.00105	0.019	CbGeAlD
Doxepin—Vision blurred—Metformin—metabolic syndrome X	0.00104	0.0103	CcSEcCtD
Doxepin—Tremor—Metformin—metabolic syndrome X	0.00103	0.0103	CcSEcCtD
Doxepin—Ill-defined disorder—Metformin—metabolic syndrome X	0.00102	0.0102	CcSEcCtD
Doxepin—Malaise—Metformin—metabolic syndrome X	0.000996	0.0099	CcSEcCtD
Doxepin—Syncope—Metformin—metabolic syndrome X	0.00099	0.00984	CcSEcCtD
Doxepin—Palpitations—Metformin—metabolic syndrome X	0.000976	0.0097	CcSEcCtD
Doxepin—Loss of consciousness—Metformin—metabolic syndrome X	0.000971	0.00964	CcSEcCtD
Doxepin—Hypertension—Metformin—metabolic syndrome X	0.000954	0.00947	CcSEcCtD
Doxepin—Myalgia—Metformin—metabolic syndrome X	0.00094	0.00934	CcSEcCtD
Doxepin—Chest pain—Metformin—metabolic syndrome X	0.00094	0.00934	CcSEcCtD
Doxepin—HTR1A—cardiovascular system—metabolic syndrome X	0.000937	0.017	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000934	0.00928	CcSEcCtD
Doxepin—Discomfort—Metformin—metabolic syndrome X	0.000929	0.00923	CcSEcCtD
Doxepin—HTR2B—adipose tissue—metabolic syndrome X	0.000923	0.0167	CbGeAlD
Doxepin—CHRM3—kidney—metabolic syndrome X	0.000921	0.0167	CbGeAlD
Doxepin—Oedema—Metformin—metabolic syndrome X	0.000901	0.00896	CcSEcCtD
Doxepin—Infection—Metformin—metabolic syndrome X	0.000895	0.0089	CcSEcCtD
Doxepin—Shock—Metformin—metabolic syndrome X	0.000887	0.00881	CcSEcCtD
Doxepin—Nervous system disorder—Metformin—metabolic syndrome X	0.000884	0.00878	CcSEcCtD
Doxepin—Thrombocytopenia—Metformin—metabolic syndrome X	0.000883	0.00877	CcSEcCtD
Doxepin—Skin disorder—Metformin—metabolic syndrome X	0.000876	0.0087	CcSEcCtD
Doxepin—Hyperhidrosis—Metformin—metabolic syndrome X	0.000871	0.00866	CcSEcCtD
Doxepin—ADRA1A—cardiovascular system—metabolic syndrome X	0.000864	0.0157	CbGeAlD
Doxepin—Anorexia—Metformin—metabolic syndrome X	0.000859	0.00854	CcSEcCtD
Doxepin—Hypotension—Metformin—metabolic syndrome X	0.000842	0.00837	CcSEcCtD
Doxepin—KCNH2—cardiovascular system—metabolic syndrome X	0.000835	0.0151	CbGeAlD
Doxepin—CHRM3—adipose tissue—metabolic syndrome X	0.00083	0.0151	CbGeAlD
Doxepin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000821	0.00816	CcSEcCtD
Doxepin—ABCB1—blood vessel—metabolic syndrome X	0.000821	0.0149	CbGeAlD
Doxepin—Paraesthesia—Metformin—metabolic syndrome X	0.000809	0.00804	CcSEcCtD
Doxepin—ADRA2C—kidney—metabolic syndrome X	0.000806	0.0146	CbGeAlD
Doxepin—Dyspnoea—Metformin—metabolic syndrome X	0.000804	0.00798	CcSEcCtD
Doxepin—Somnolence—Metformin—metabolic syndrome X	0.000801	0.00796	CcSEcCtD
Doxepin—Dyspepsia—Metformin—metabolic syndrome X	0.000793	0.00788	CcSEcCtD
Doxepin—Decreased appetite—Metformin—metabolic syndrome X	0.000784	0.00779	CcSEcCtD
Doxepin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000778	0.00773	CcSEcCtD
Doxepin—Fatigue—Metformin—metabolic syndrome X	0.000777	0.00772	CcSEcCtD
Doxepin—Constipation—Metformin—metabolic syndrome X	0.000771	0.00766	CcSEcCtD
Doxepin—ORM1—liver—metabolic syndrome X	0.000766	0.0139	CbGeAlD
Doxepin—ADRA1A—adipose tissue—metabolic syndrome X	0.000762	0.0138	CbGeAlD
Doxepin—Feeling abnormal—Metformin—metabolic syndrome X	0.000743	0.00738	CcSEcCtD
Doxepin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000737	0.00732	CcSEcCtD
Doxepin—ADRA2C—adipose tissue—metabolic syndrome X	0.000726	0.0132	CbGeAlD
Doxepin—Urticaria—Metformin—metabolic syndrome X	0.000716	0.00711	CcSEcCtD
Doxepin—Abdominal pain—Metformin—metabolic syndrome X	0.000713	0.00708	CcSEcCtD
Doxepin—CYP2C9—cardiovascular system—metabolic syndrome X	0.000678	0.0123	CbGeAlD
Doxepin—Asthenia—Metformin—metabolic syndrome X	0.000647	0.00643	CcSEcCtD
Doxepin—Pruritus—Metformin—metabolic syndrome X	0.000638	0.00634	CcSEcCtD
Doxepin—Diarrhoea—Metformin—metabolic syndrome X	0.000617	0.00613	CcSEcCtD
Doxepin—Thiothixene—HTR2C—metabolic syndrome X	0.000602	0.12	CrCbGaD
Doxepin—Dizziness—Metformin—metabolic syndrome X	0.000596	0.00592	CcSEcCtD
Doxepin—HRH1—adipose tissue—metabolic syndrome X	0.00059	0.0107	CbGeAlD
Doxepin—ADRA2A—adipose tissue—metabolic syndrome X	0.000579	0.0105	CbGeAlD
Doxepin—Vomiting—Metformin—metabolic syndrome X	0.000573	0.00569	CcSEcCtD
Doxepin—Rash—Metformin—metabolic syndrome X	0.000568	0.00565	CcSEcCtD
Doxepin—Dermatitis—Metformin—metabolic syndrome X	0.000568	0.00564	CcSEcCtD
Doxepin—Headache—Metformin—metabolic syndrome X	0.000565	0.00561	CcSEcCtD
Doxepin—HTR2A—cardiovascular system—metabolic syndrome X	0.000559	0.0101	CbGeAlD
Doxepin—HTR2A—kidney—metabolic syndrome X	0.000547	0.00992	CbGeAlD
Doxepin—CYP2C19—liver—metabolic syndrome X	0.000541	0.00982	CbGeAlD
Doxepin—Nausea—Metformin—metabolic syndrome X	0.000535	0.00532	CcSEcCtD
Doxepin—ADRA1A—liver—metabolic syndrome X	0.000534	0.0097	CbGeAlD
Doxepin—ADRA2C—liver—metabolic syndrome X	0.000509	0.00924	CbGeAlD
Doxepin—CYP3A4—kidney—metabolic syndrome X	0.000506	0.00919	CbGeAlD
Doxepin—CYP2D6—kidney—metabolic syndrome X	0.000498	0.00904	CbGeAlD
Doxepin—Clomipramine—HTR2C—metabolic syndrome X	0.000476	0.0946	CrCbGaD
Doxepin—Chlorprothixene—HTR2C—metabolic syndrome X	0.000474	0.0942	CrCbGaD
Doxepin—Nortriptyline—HTR2C—metabolic syndrome X	0.000465	0.0925	CrCbGaD
Doxepin—CYP1A2—liver—metabolic syndrome X	0.000442	0.00802	CbGeAlD
Doxepin—Trimipramine—HTR2C—metabolic syndrome X	0.000438	0.0871	CrCbGaD
Doxepin—CYP2C9—liver—metabolic syndrome X	0.000419	0.00761	CbGeAlD
Doxepin—Desipramine—HTR2C—metabolic syndrome X	0.000383	0.0761	CrCbGaD
Doxepin—Promazine—HTR2C—metabolic syndrome X	0.000371	0.0737	CrCbGaD
Doxepin—ABCB1—cardiovascular system—metabolic syndrome X	0.000366	0.00665	CbGeAlD
Doxepin—Oxcarbazepine—ALB—metabolic syndrome X	0.000361	0.0718	CrCbGaD
Doxepin—ABCB1—kidney—metabolic syndrome X	0.000358	0.0065	CbGeAlD
Doxepin—HTR2A—liver—metabolic syndrome X	0.000345	0.00627	CbGeAlD
Doxepin—Imipramine—HTR2C—metabolic syndrome X	0.000325	0.0646	CrCbGaD
Doxepin—Amitriptyline—HTR2C—metabolic syndrome X	0.000323	0.0642	CrCbGaD
Doxepin—ABCB1—adipose tissue—metabolic syndrome X	0.000323	0.00586	CbGeAlD
Doxepin—CYP3A4—liver—metabolic syndrome X	0.00032	0.00581	CbGeAlD
Doxepin—CYP2D6—liver—metabolic syndrome X	0.000315	0.00571	CbGeAlD
Doxepin—Thiothixene—ALB—metabolic syndrome X	0.000262	0.0522	CrCbGaD
Doxepin—ABCB1—liver—metabolic syndrome X	0.000226	0.00411	CbGeAlD
Doxepin—Clomipramine—ALB—metabolic syndrome X	0.000207	0.0412	CrCbGaD
Doxepin—Nortriptyline—ALB—metabolic syndrome X	0.000203	0.0403	CrCbGaD
Doxepin—Amitriptyline—ALB—metabolic syndrome X	0.000141	0.028	CrCbGaD
Doxepin—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	9.9e-06	5.94e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—NOS3—metabolic syndrome X	9.88e-06	5.93e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	9.87e-06	5.92e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.85e-06	5.91e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	9.83e-06	5.9e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.83e-06	5.9e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.83e-06	5.9e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.77e-06	5.87e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOB—metabolic syndrome X	9.76e-06	5.86e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	9.74e-06	5.85e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.72e-06	5.84e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CD36—metabolic syndrome X	9.72e-06	5.83e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	9.71e-06	5.83e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—INS—metabolic syndrome X	9.65e-06	5.8e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	9.64e-06	5.79e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	9.62e-06	5.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	9.59e-06	5.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	9.58e-06	5.75e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	9.56e-06	5.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—INS—metabolic syndrome X	9.5e-06	5.7e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	9.5e-06	5.7e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	9.5e-06	5.7e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CD36—metabolic syndrome X	9.48e-06	5.69e-05	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	9.48e-06	5.69e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—INS—metabolic syndrome X	9.48e-06	5.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—metabolic syndrome X	9.48e-06	5.69e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—INS—metabolic syndrome X	9.45e-06	5.67e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—INS—metabolic syndrome X	9.42e-06	5.65e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—LPL—metabolic syndrome X	9.4e-06	5.65e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	9.35e-06	5.61e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	9.34e-06	5.61e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	9.33e-06	5.6e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	9.33e-06	5.6e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—INS—metabolic syndrome X	9.33e-06	5.6e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	9.33e-06	5.6e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—LPL—metabolic syndrome X	9.32e-06	5.6e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	9.31e-06	5.59e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	9.3e-06	5.58e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	9.3e-06	5.58e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	9.27e-06	5.56e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.25e-06	5.56e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	9.19e-06	5.52e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	9.18e-06	5.51e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	9.18e-06	5.51e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	9.17e-06	5.5e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	9.16e-06	5.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	9.15e-06	5.49e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	9.14e-06	5.49e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	9.11e-06	5.47e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—NOS3—metabolic syndrome X	9.06e-06	5.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	9.04e-06	5.43e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—metabolic syndrome X	9.03e-06	5.42e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARA—metabolic syndrome X	9.03e-06	5.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	9.02e-06	5.42e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	9.02e-06	5.42e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	9e-06	5.4e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CD36—metabolic syndrome X	8.94e-06	5.37e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.87e-06	5.32e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CD36—metabolic syndrome X	8.86e-06	5.32e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARA—metabolic syndrome X	8.82e-06	5.29e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.79e-06	5.28e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.79e-06	5.28e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AGT—metabolic syndrome X	8.75e-06	5.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.73e-06	5.24e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.71e-06	5.23e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.68e-06	5.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	8.65e-06	5.19e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	8.64e-06	5.19e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	8.61e-06	5.17e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	8.61e-06	5.17e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—metabolic syndrome X	8.57e-06	5.15e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.57e-06	5.14e-05	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.56e-06	5.14e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.54e-06	5.13e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AGT—metabolic syndrome X	8.54e-06	5.13e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	8.5e-06	5.1e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOA1—metabolic syndrome X	8.47e-06	5.09e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	8.47e-06	5.08e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—metabolic syndrome X	8.46e-06	5.08e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	8.43e-06	5.06e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—metabolic syndrome X	8.37e-06	5.02e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	8.36e-06	5.02e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOB—metabolic syndrome X	8.34e-06	5.01e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	8.33e-06	5e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	8.31e-06	4.99e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARA—metabolic syndrome X	8.31e-06	4.99e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	8.29e-06	4.98e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	8.29e-06	4.97e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOA1—metabolic syndrome X	8.27e-06	4.97e-05	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.26e-06	4.96e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	8.26e-06	4.96e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARA—metabolic syndrome X	8.24e-06	4.94e-05	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.22e-06	4.94e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	8.18e-06	4.91e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.16e-06	4.9e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	8.13e-06	4.88e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	8.13e-06	4.88e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	8.12e-06	4.87e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	8.09e-06	4.86e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AGT—metabolic syndrome X	8.05e-06	4.83e-05	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8e-06	4.8e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGT—metabolic syndrome X	7.98e-06	4.79e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.97e-06	4.78e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.94e-06	4.77e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.88e-06	4.73e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	7.87e-06	4.73e-05	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.87e-06	4.72e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.86e-06	4.72e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.84e-06	4.7e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.84e-06	4.7e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—metabolic syndrome X	7.82e-06	4.69e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—metabolic syndrome X	7.81e-06	4.69e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.79e-06	4.68e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	7.78e-06	4.67e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	7.77e-06	4.67e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	7.75e-06	4.65e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOA1—metabolic syndrome X	7.73e-06	4.64e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.59e-06	4.56e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.59e-06	4.56e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	7.58e-06	4.55e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.57e-06	4.54e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.5e-06	4.5e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—metabolic syndrome X	7.47e-06	4.48e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.46e-06	4.48e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—metabolic syndrome X	7.32e-06	4.4e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	7.32e-06	4.39e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—metabolic syndrome X	7.29e-06	4.37e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.26e-06	4.36e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.25e-06	4.36e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—metabolic syndrome X	7.15e-06	4.29e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	7.15e-06	4.29e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	7.14e-06	4.29e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.14e-06	4.29e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.12e-06	4.28e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.1e-06	4.26e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	7.08e-06	4.25e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARA—metabolic syndrome X	7.04e-06	4.23e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	7.03e-06	4.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	7.01e-06	4.21e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.01e-06	4.21e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.99e-06	4.2e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	6.99e-06	4.2e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	6.97e-06	4.18e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	6.9e-06	4.14e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	6.88e-06	4.13e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.87e-06	4.12e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.82e-06	4.09e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—metabolic syndrome X	6.81e-06	4.09e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—metabolic syndrome X	6.73e-06	4.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—metabolic syndrome X	6.71e-06	4.03e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.68e-06	4.01e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—metabolic syndrome X	6.68e-06	4.01e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.6e-06	3.97e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.6e-06	3.96e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	6.59e-06	3.96e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—metabolic syndrome X	6.55e-06	3.93e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.49e-06	3.9e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—metabolic syndrome X	6.49e-06	3.9e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.48e-06	3.89e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6.47e-06	3.88e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	6.45e-06	3.87e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.44e-06	3.87e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	6.43e-06	3.86e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—metabolic syndrome X	6.42e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.39e-06	3.84e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.38e-06	3.83e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	6.36e-06	3.82e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.35e-06	3.81e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.34e-06	3.81e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—metabolic syndrome X	6.27e-06	3.76e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.26e-06	3.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.17e-06	3.71e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.17e-06	3.7e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.15e-06	3.69e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	6.12e-06	3.68e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—metabolic syndrome X	6.12e-06	3.67e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	6.07e-06	3.65e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.99e-06	3.6e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	5.92e-06	3.56e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.91e-06	3.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.9e-06	3.54e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	5.87e-06	3.53e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	5.86e-06	3.52e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5.85e-06	3.52e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.84e-06	3.51e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.82e-06	3.49e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	5.73e-06	3.44e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—metabolic syndrome X	5.71e-06	3.43e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	5.65e-06	3.39e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	5.6e-06	3.36e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	5.51e-06	3.31e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.51e-06	3.31e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.5e-06	3.3e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	5.48e-06	3.29e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	5.47e-06	3.28e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	5.46e-06	3.28e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.43e-06	3.26e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	5.41e-06	3.25e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	5.41e-06	3.25e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.4e-06	3.24e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.39e-06	3.24e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	5.35e-06	3.22e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.26e-06	3.16e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.23e-06	3.14e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.15e-06	3.09e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.13e-06	3.08e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.09e-06	3.06e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	5.09e-06	3.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.01e-06	3.01e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5e-06	3e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.98e-06	2.99e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.8e-06	2.88e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.78e-06	2.87e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.65e-06	2.79e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	4.59e-06	2.76e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.58e-06	2.75e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	4.58e-06	2.75e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—metabolic syndrome X	4.54e-06	2.73e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.49e-06	2.7e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.43e-06	2.66e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.41e-06	2.65e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—metabolic syndrome X	4.4e-06	2.64e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.29e-06	2.58e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	4.22e-06	2.53e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.22e-06	2.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.17e-06	2.5e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.15e-06	2.49e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.14e-06	2.49e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	4.13e-06	2.48e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	4.12e-06	2.47e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	4.08e-06	2.45e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.06e-06	2.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.04e-06	2.42e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.89e-06	2.34e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.86e-06	2.32e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.83e-06	2.3e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.82e-06	2.29e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.81e-06	2.29e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.8e-06	2.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.78e-06	2.27e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.76e-06	2.26e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.75e-06	2.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.53e-06	2.12e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.48e-06	2.09e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—metabolic syndrome X	2.95e-06	1.77e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.88e-06	1.73e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.71e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.69e-06	1.62e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.3e-06	1.38e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.77e-06	1.07e-05	CbGpPWpGaD
